IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT

Leukemia

Volumn 26, Issue 11, 2012, Pages 2435-2439

  Pfeiffer, M M ^a   Schumm, M ^a   Müller, Ingo ^b   Handgretinger, R ^a   Lang, P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2;

ALLOIMMUNITY; ANTIGEN EXPRESSION; CELL PROLIFERATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; FLOW CYTOMETRY; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LETTER; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANTIGENS, CD19; ANTIGENS, CD3; CHILD; FLOW CYTOMETRY; HAPLOTYPES; HUMANS; INTERLEUKIN-15; LEUKEMIA; RECURRENCE; STEM CELL TRANSPLANTATION;

EID: 84869090132     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.167     Document Type: Letter

References (8)

1. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100. (Pubitemid 34229476)
2. Leung W, Iyengar R, Turner V, Lang P, BaDer P, Conn P et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644-650. (Pubitemid 38020523)
3. Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood 2007; 109: 5058-5061. (Pubitemid 46827806)
4. Schumm M, Handgretinger R, Pfeiffer M, Feuchtinger T, Kuci S, Faul C et al. Determination of residual T- and B-cell content after immunomagnetic depletion: Proposal for flow cytometric analysis and results from 103 separations. Cytotherapy 2006; 8: 465-472. (Pubitemid 44596999)
5. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005; 105: 3051-3057.
6. Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T et al. NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol 2010; 28: 955-959.
7. Lang P, Pfeiffer M, Handgretinger R, Schumm M, Demirdelen B, Stanojevic S et al. Clinical scale isolation of T cell-depleted CD56 donor lymphocytes in children. Bone Marrow Transplant 2002; 29: 497-502. (Pubitemid 34428718)
8. Koehl U, Sorensen J, Esser R, Zimmermann S, Grü ttner HP, Tonn T et al. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol Dis 2004; 33: 261-266. (Pubitemid 39446496)